Christopher Mirabelli - Jan 31, 2022 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role: Director, Chairman of the Board, 10%+ Owner
Signature: /s/ Douglas E. Onsi, as attorney-in-fact for Christopher Mirabelli
Stock symbol: LPTX
Transactions as of: Jan 31, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/2/2022, 08:48 PM
Previous filing: May 28, 2021
Next filing: Sep 2, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LPTX	Restricted Stock Units	Award	$0	+225K		$0.00	225K	Jan 31, 2022	Common Stock	225K	$0.00	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Stock Units were awarded pursuant to Leap's 2016 Equity Incentive Plan for no consideration. Restricted Stock Units will be settled in common stock.
F2	The Restricted Stock Units will cliff vest and be settled after three years of continuous service or upon a change of control of Leap, whichever is earlier.